Search over 3,000 reports

    Atopic Dermatitis (AD) - Market Insights, Epidemiology and Market Forecast - 2025

    Atopic Dermatitis (AD) - Market Insights, Epidemiology and Market Forecast - 2025
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 144
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIMI0253
    DelveInsight's "Atopic Dermatitis (AD) - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Atopic Dermatitis (AD) for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025.

    This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Atopic Dermatitis (AD) . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Atopic Dermatitis (AD) for 7 major markets. The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the

    Report highlights the frontrunners, the drivers and barriers for the Atopic Dermatitis (AD) market, as well as treatment algorithm, current treatments & advancements are included.
    The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Atopic Dermatitis (AD) , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

    According to DelveInsight, the forecasted patient population of Atopic Dermatitis (AD) for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Atopic Dermatitis (AD) 7MM market size is estimated to be USD XX by 2025. The DelveInsight Report will help in enhanced understanding of the Atopic Dermatitis (AD) market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

    Key Coverage

    • Understanding historical and forecasted epidemiological data for Atopic Dermatitis (AD) covering 7MM from 2015-2025.
    • Segment level epidemiology and market split for Atopic Dermatitis (AD) .
    • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Atopic Dermatitis (AD) .
    • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Atopic Dermatitis (AD) market trends.
    • Thorough market distribution based on market share for Atopic Dermatitis (AD) .

    Reasons to buy:

    • The report will help in developing business strategies by understanding trends shaping and driving the Atopic Dermatitis (AD) market.
    • To understand the future market competition in the Atopic Dermatitis (AD) market and Insightful review of the key market drivers and barriers.
    • Organize sales and marketing efforts by identifying the best opportunities for Atopic Dermatitis (AD) in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
    • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.
    1. Report Introduction
    2. Atopic Dermatitis (AD) Market Overview at a Glance
    2.1. Total Market Share Distribution of Atopic Dermatitis (AD) for 7 MM in 2016
    2.2. Total Market Share Distribution of Atopic Dermatitis (AD) for 7 MM in 2025
    3. Atopic Dermatitis (AD)
    3.1.1. Overview
    3.1.2. Symptoms
    3.1.3. Pathophysiology
    3.1.4. Staging
    3.1.5. Diagnosis
    3.1.6. Treatment
    4. Epidemiology and Patient Population
    4.1.1. United States
    4.1.1.1. Diagnosed Cases of Atopic Dermatitis (AD) in United States
    4.1.2. Germany
    4.1.2.1. Diagnosed Cases of Atopic Dermatitis (AD) in Germany
    4.1.3. France
    4.1.3.1. Diagnosed Cases of Atopic Dermatitis (AD) in France
    4.1.4. Italy
    4.1.4.1. Diagnosed Cases of Atopic Dermatitis (AD) in Italy
    4.1.5. Spain
    4.1.5.1. Diagnosed Cases of Atopic Dermatitis (AD) in Spain
    4.1.6. United Kingdom
    4.1.6.1. Diagnosed Cases of Atopic Dermatitis (AD) in United Kingdom
    5. Treatment Algorithm
    5.1.1. Treatment Guidelines/Practices
    6. Marketed Drugs for Atopic Dermatitis (AD)
    6.1. Drug 1: Company A
    6.1.1. Drug Description
    6.1.2. Mechanism of Action
    6.1.3. Regulatory Milestones
    6.1.4. Advantages & Disadvantages
    6.1.5. Safety and Efficacy
    6.1.6. Product Profile
    6.1.7. Patent Status
    6.2. Drug 2: Company B
    6.2.1. Drug Description
    6.2.2. Mechanism of Action
    6.2.3. Regulatory Milestones
    6.2.4. Advantages & Disadvantages
    6.2.5. Safety and Efficacy
    6.2.6. Product Profile
    6.2.7. Patent Status
    7. Emerging Therapies
    7.1. Drug 3: Company C
    7.1.1. Description
    7.1.2. Regulatory Milestones
    7.1.3. Advantages & Disadvantages
    7.1.4. Product Profile
    7.1.5. Launch Date
    7.1.6. Clinical Development
    7.1.7. Clinical Pipeline Activity
    7.1.8. Ongoing Trials Information
    7.1.9. Clinical Trial by Phase
    7.2. Drug 4: Company B
    7.2.1. Description
    7.2.2. Regulatory Milestones
    7.2.3. Advantages & Disadvantages
    7.2.4. Product Profile
    7.2.5. Launch Date
    7.2.6. Clinical Development
    7.2.7. Clinical Pipeline Activity
    7.2.8. Ongoing Trials Information
    7.2.9. Clinical Trial by Phase
    8. Overview of Total Atopic Dermatitis (AD) Market (2016 & 2025)
    9. Atopic Dermatitis (AD): Country-Wise Market Analysis
    9.1. United States
    9.1.1. Historical Market Size (2015-2016)
    9.1.2. Forecasted Market Size (2017-2025)
    9.2. Germany Market Size
    9.2.1. Historical Market Size (2015-2016)
    9.2.2. Forecasted Market Size (2017-2025)
    9.3. France Market Size
    9.3.1. Historical Market Size (2015-2016)
    9.3.2. Forecasted Market Size (2017-2025)
    9.4. United Kingdom Market Size
    9.4.1. Historical Market Size (2015-2016)
    9.4.2. Forecasted Market Size (2017-2025)
    9.5. Spain Market Size
    9.5.1. Historical Market Size (2015-2016)
    9.5.2. Forecasted Market Size (2017-2025)
    9.6. Italy Market Size
    9.6.1. Historical Market Size (2015-2016)
    9.6.2. Forecasted Market Size (2017-2025)
    9.7. Japan Market Size
    9.7.1. Historical Market Size (2015-2016)
    9.7.2. Forecasted Market Size (2017-2025)
    10. Market Drivers
    11. Market Restraints
    12. Appendix
    13. Report Methodology
    14. Consulting Services
    15. Disclaimer
    16. About DelveInsight


    List of Tables

    Table 1: Diagnosed Cases Atopic Dermatitis (AD) in United States (2015-2025)
    Table 2: Diagnosed Cases Atopic Dermatitis (AD) in Germany (2015-2025)
    Table 3: Diagnosed Cases Atopic Dermatitis (AD) in France (2015-2025)
    Table 4: Diagnosed Cases Atopic Dermatitis (AD) in United Kingdom (2015-2025)
    Table 5: Diagnosed Cases Atopic Dermatitis (AD) in Spain (2015-2025)
    Table 6: Diagnosed Cases Atopic Dermatitis (AD) in Italy (2015-2025)
    Table 7: Diagnosed Cases Atopic Dermatitis (AD) in Japan (2015-2025)
    Table 8: List of Marketed Drugs for Atopic Dermatitis (AD)
    Table 9: List of Pipeline Phase III Drugs for Atopic Dermatitis (AD)
    Table 10: Drug 1, Clinical Trials by Zone, 2017
    Table 11: Clinical Trials by Trial status, 2017
    Table 12: Drug 2, Clinical Trials by Zone, 2017
    Table 13: Clinical Trials by Trial status, 2017
    Table 14: Drug 3, Clinical Trials by Zone, 2017
    Table 15: Clinical Trials by Trial status, 2017
    Table 16: United States Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 17: Germany Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 18: France Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 19: United Kingdom Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 20: Spain Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 21: Italy Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 22: Japan Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)

    List of Figures
    Figure 1: Diagnosed Cases Atopic Dermatitis (AD) in United States (2015-2025)
    Figure 2: Diagnosed Cases Atopic Dermatitis (AD) in Germany (2015-2025)
    Figure 3: Diagnosed Cases Atopic Dermatitis (AD) in France (2015-2025)
    Figure 4: Diagnosed Cases Atopic Dermatitis (AD) in United Kingdom (2015-2025)
    Figure 5: Diagnosed Cases Atopic Dermatitis (AD) in Spain (2015-2025)
    Figure 6: Diagnosed Cases Atopic Dermatitis (AD) in Italy (2015-2025)
    Figure 7: Diagnosed Cases Atopic Dermatitis (AD) in Japan (2015-2025)
    Figure 8: List of Marketed Drugs for Atopic Dermatitis (AD)
    Figure 9: List of Pipeline Phase III Drugs for Atopic Dermatitis (AD)
    Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
    Figure 11: Clinical Trials by Trial status, 2017
    Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
    Figure 13: Clinical Trials by Trial status, 2017
    Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
    Figure 15: Clinical Trials by Trial status, 2017
    Figure 16: United States Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 17: Germany Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 18: France Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 19: United Kingdom Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 20: Spain Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 21: Italy Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 22: Japan Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Atopic Dermatitis (AD) Market (7MM)
    Atopic Dermatitis (AD) Market forecasting
    Atopic Dermatitis (AD) Sales forecasting
    Atopic Dermatitis (AD) Market segments
    Atopic Dermatitis (AD) Epidemiology
    Atopic Dermatitis (AD) Pipeline products and technologies
    Atopic Dermatitis (AD) Competitive landscape
    Atopic Dermatitis (AD) SWOT analysis
    Atopic Dermatitis (AD) Market Driver's and barriers
    Atopic Dermatitis (AD) Key Companies and Funding
    Table 1: Diagnosed Cases Atopic Dermatitis (AD) in United States (2015-2025)
    Table 2: Diagnosed Cases Atopic Dermatitis (AD) in Germany (2015-2025)
    Table 3: Diagnosed Cases Atopic Dermatitis (AD) in France (2015-2025)
    Table 4: Diagnosed Cases Atopic Dermatitis (AD) in United Kingdom (2015-2025)
    Table 5: Diagnosed Cases Atopic Dermatitis (AD) in Spain (2015-2025)
    Table 6: Diagnosed Cases Atopic Dermatitis (AD) in Italy (2015-2025)
    Table 7: Diagnosed Cases Atopic Dermatitis (AD) in Japan (2015-2025)
    Table 8: List of Marketed Drugs for Atopic Dermatitis (AD)
    Table 9: List of Pipeline Phase III Drugs for Atopic Dermatitis (AD)
    Table 10: Drug 1, Clinical Trials by Zone, 2017
    Table 11: Clinical Trials by Trial status, 2017
    Table 12: Drug 2, Clinical Trials by Zone, 2017
    Table 13: Clinical Trials by Trial status, 2017
    Table 14: Drug 3, Clinical Trials by Zone, 2017
    Table 15: Clinical Trials by Trial status, 2017
    Table 16: United States Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 17: Germany Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 18: France Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 19: United Kingdom Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 20: Spain Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 21: Italy Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Table 22: Japan Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)

    Figure 1: Diagnosed Cases Atopic Dermatitis (AD) in United States (2015-2025)
    Figure 2: Diagnosed Cases Atopic Dermatitis (AD) in Germany (2015-2025)
    Figure 3: Diagnosed Cases Atopic Dermatitis (AD) in France (2015-2025)
    Figure 4: Diagnosed Cases Atopic Dermatitis (AD) in United Kingdom (2015-2025)
    Figure 5: Diagnosed Cases Atopic Dermatitis (AD) in Spain (2015-2025)
    Figure 6: Diagnosed Cases Atopic Dermatitis (AD) in Italy (2015-2025)
    Figure 7: Diagnosed Cases Atopic Dermatitis (AD) in Japan (2015-2025)
    Figure 8: List of Marketed Drugs for Atopic Dermatitis (AD)
    Figure 9: List of Pipeline Phase III Drugs for Atopic Dermatitis (AD)
    Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
    Figure 11: Clinical Trials by Trial status, 2017
    Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
    Figure 13: Clinical Trials by Trial status, 2017
    Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
    Figure 15: Clinical Trials by Trial status, 2017
    Figure 16: United States Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 17: Germany Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 18: France Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 19: United Kingdom Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 20: Spain Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 21: Italy Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Figure 22: Japan Market Size of Atopic Dermatitis (AD) in USD, Million (2015-2025)
    Atopic Dermatitis (AD) Market (7MM)

    Atopic Dermatitis (AD) Market forecasting

    Atopic Dermatitis (AD) Sales forecasting

    Atopic Dermatitis (AD) Market segments

    Atopic Dermatitis (AD) Epidemiology

    Atopic Dermatitis (AD) Pipeline products and technologies

    Atopic Dermatitis (AD) Competitive landscape

    Atopic Dermatitis (AD) SWOT analysis

    Atopic Dermatitis (AD) Market Driver's and barriers

    Atopic Dermatitis (AD) Key Companies and Funding

    • Single User License
      (20% Off)
      $5,750.00
    • Site License
      (30% Off)
      $11,500.00
    • Global License
      (40% Off)
      $17,250.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap